Parish McKinney, MD
Psychiatry · Greensboro, NCNPI 1437348398
Payments from drug & device makers
Across 36 payments — averaging $373.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$12K
- Johnson & Johnson$490
- Sunovion Pharmaceuticals Inc.$463
- AbbVie$187
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$174
- Axsome Therapeutics, Inc.$125
- plus $374 from 3 others
What the payments were for
- Speaking & faculty fees$8,88066%
- Travel & lodging$2,58019%
- Food & beverage$2,00215%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $11,649 |
| Johnson & Johnson | 5 | $490 |
| Sunovion Pharmaceuticals Inc. | 8 | $463 |
| AbbVie(2 entities) | 2 | $187 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $174 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| MDD US Operations, LLC | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Neurocrine Biosciences, Inc. | 1 | $124 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINTELLIX$11,398
- SPRAVATO$250
- LATUDA$235
- Lucemyra/Lofexidine$125
- ABILIFY MAINTENA$125
- Auvelity$125
- INGREZZA$124
- INVEGA SUSTENNA$120
- INVEGA TRINZA$120
- CAPLYTA$102
- VRAYLAR$100
How this compares
$13,462 in reported general payments places this provider in the 90th percentile of 1,108 psychiatry providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Greensboro
- Keshavpal ReddyGreensboro$480K
- Gerald PlovskyGreensboro$44K
- Craig ChepkeHuntersville$4.1M
- James BarkerHickory$4.1M
- Mark ReynoldsDurham$3.2M
- Oleg TcheremissineCharlotte$2M
- Richard WeislerRaleigh$1.2M
- Dan BlazerDurham$1M
- Samantha Meltzer-BrodyChapel Hill$909K
- Andrew KrystalDurham$754K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.